Skip to main content
Top
Published in: Journal of Cancer Education 2/2024

12-12-2023 | Ionizing Radiation

A Novel USMLE® Step 1 Based Approach to Introducing Radiation Oncology to Second-Year Preclinical Medical Students

Authors: Mary T. Mahoney, Michael D. Mix, Karna T. Sura, Lauren J. Germain

Published in: Journal of Cancer Education | Issue 2/2024

Login to get access

Abstract

There is a paucity of formalized exposure to Radiation Oncology (RO) for preclinical medical students across the United States as well as barriers to implementation within undergraduate medical education curriculum at many institutions. We present a novel approach to implementing an introductory RO didactic lecture to second-year medical students by interweaving associated oncological and ionizing radiation content represented on the United States Medical Licensing Exam® (USMLE®) Step 1 examination. Students had synchronous and asynchronous opportunities to engage with the 1.0-h didactic lecture administered by an attending Radiation Oncologist faculty member. Students were electronically invited to anonymously rank the effectiveness of the lecture materials on a 5-point Likert scale. Performance on standardized board-style questions regarding radiation biology and radiation side effects was recorded before and after the lecture and compared to the historic performance of previous institutional second-year medical student cohorts. The lecture material effectiveness received a mean score of 4.50 on a 5-point Likert scale. There was a statistically significant improvement in student performance on a board-style radiation side effect question from 39% on a pretest to 76% on a posttest. A USMLE® topic-based approach may be an effective way to implement a formalized introduction to RO to preclinical medical students while simultaneously improving performance on relevant standardized board-style questions. Providing evidence that RO topics appear on the USMLE® Step 1 examination curriculum was a powerful incentive for implementation when negotiating with curriculum offices.
Appendix
Available only for authorised users
Literature
5.
go back to reference Biswal BM, Zakaria A, Baba AA, Ja’afar R (2004) Assessment of knowledge, attitude and exposure to oncology and palliative care in undergraduate medical students. Med J Malaysia 59(1):78–83PubMed Biswal BM, Zakaria A, Baba AA, Ja’afar R (2004) Assessment of knowledge, attitude and exposure to oncology and palliative care in undergraduate medical students. Med J Malaysia 59(1):78–83PubMed
14.
go back to reference Le T, Bhushan V, Sochat M et al (2022) First Aid for the USMLE Step 1 2022 32. McGraw Hill, Columbus Le T, Bhushan V, Sochat M et al (2022) First Aid for the USMLE Step 1 2022 32. McGraw Hill, Columbus
15.
go back to reference Sattar HA (2021) Fundamentals of pathology: medical course and step 1 review. Pathoma LLC, Chicago Sattar HA (2021) Fundamentals of pathology: medical course and step 1 review. Pathoma LLC, Chicago
16.
go back to reference Kirkpatrick DL, Kirkpatrick JD (2006) Evaluating Training programs: the four levels, third edition, 3rd edn. Berrett-Koehler Publishers, San Francisco Kirkpatrick DL, Kirkpatrick JD (2006) Evaluating Training programs: the four levels, third edition, 3rd edn. Berrett-Koehler Publishers, San Francisco
Metadata
Title
A Novel USMLE® Step 1 Based Approach to Introducing Radiation Oncology to Second-Year Preclinical Medical Students
Authors
Mary T. Mahoney
Michael D. Mix
Karna T. Sura
Lauren J. Germain
Publication date
12-12-2023
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 2/2024
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-023-02390-w

Other articles of this Issue 2/2024

Journal of Cancer Education 2/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine